He aha ka Anandamide (AEA)

Anandamide (AEA), ʻike ʻia ʻo ka mole mole hauʻoli, a i ʻole N-arachidonoylethanolamine (AEA), he neurotransmitter waikawa momona. Loaʻa ka inoa Anadamida (AEA) mai ka Sanskrit o Joy "Ananda." ʻO Raphael Mechoulam i haku i kēia huaʻōlelo. Pehea, me kāna mau mea kōkua ʻelua, ʻo WA Devane lāua ʻo Lumír Hanuš, i ʻike mua iā “Anandamide” i ka makahiki 1992. ʻO Anandamide (AEA) kahi hoʻoponopono maikaʻi loa no ka nui o kā mākou pilikia kino a me ka noʻonoʻo.

He aha ka Cannabidiol (CBD)?

Cannabidiol (CBD) ʻo ia ka lua o ka nui o nā pūhui hana i ʻike ʻia ma ke ʻano he cannabinoids i loaʻa i loko o ka cannabis sativa (mariuana a hemp). ʻO Tetrahydrocannabinol (THC) ka mea nui a me ka psychoactive cannabinoid i loaʻa i ka mea kanu lāʻau. Pili ka THC me ka loaʻa ʻana o kahi manaʻo "kiʻekiʻe".
Eia naʻe, ʻaʻohe psychoactive ʻo CBD a loaʻa mai ia i ka mea kanu hemp i loaʻa nā helu haʻahaʻa o THC. ʻO kēia waiwai ka mea i loaʻa iā CBD ka kaulana i ka ʻāpana olakino a olakino.
ʻO ka aila Cannabidiol (CBD) ma ka ʻaoʻao ʻē aʻe i lawe ʻia mai ka mea kanu cannabis ma o ka hoʻohui ʻana i ka CBD i lawe ʻia i ka aila lawe e like me ka aila hua hemp a i ʻole ka aila niu.

Nānā Anandamide & Cannabidiol

He aha ka Anandamide?

ʻO Anandamide, ʻo ia hoʻi ʻo N-arachidonoylethanolamine, kahi neurotransmitter waikawa momona i lawe ʻia mai ka metabolism non-oxidative o eicosatetraenoic acid, kahi omega-6 fatty acid pono. Lawe ʻia ka inoa mai ka huaʻōlelo Sanskrit ananda, ʻo ia hoʻi "hauʻoli, hauʻoli, hauʻoli", a me ka amide.

ʻO ka anandamide kahi hormone?

Hāʻawi ka noiʻi i ka loulou mua ma waena o ka oxytocin - i kapa ʻia ʻo "hormone aloha" - a me anandamide, i kapa ʻia ʻo "mole mole hauʻoli" no kāna hana i ka hoʻoulu ʻana i nā pūkana cannabinoid i loko o nā lolo e hoʻonui i ka hoʻoikaika a me ka hauʻoli.

He mea hoʻonāukiuki a aniani paha ʻo anandamide?

I ka hopena, ʻo nā mea loaʻa cannabinoid o ka ʻano CB1 a me ko lākou ligand endogeneous, anandamide, i loko o ka kaohi o ka neuronal excite .

He aha nā endocannabinoids ʻelua i noiʻi nui ʻia e ke kino e hana maoli ai?

Kuhi nā kānaka noiʻi aia paha he kolu o ka poʻe loaʻa cannabinoid e kali ana e ʻike ʻia. ʻO Endocannabinoids nā mea a ko mākou kino e hana maoli ai e hoʻonāukiuki i kēia mau mea loaʻa. Ua kapa ʻia nā mea ʻelua i maopopo loa o kēia mau molekiola anandamide a me 2-arachidonoylglycerol (2-AG).

Loaʻa kahi ʻōnaehana cannabinoid i ke kino o ke kanaka?

ʻO ka ʻōnaehana cannabinoid endogenous - kapa ʻia no ka mea kanu i alakaʻi ʻia i kona loaʻa ʻana - kekahi o nā ʻōnaehana physiologic nui e pili ana i ka hoʻokumu a mālama ʻana i ke olakino kanaka. Loaʻa nā endocannabinoids a me kā lākou mau pane i loko o ke kino: i ka lolo, nā ʻokena, nā mea hoʻopili, nā glands, a me nā hunaola pale.

He aha ka mea i loaʻa i ka cannabinoid mua?

I ka 1992, ua hoʻokaʻawale ka hale hana o Mechoulam i ka endocannabinoid mua: kahi mole i hoʻokaʻawale ʻia ma ke ʻano he agonist hapa CB1. Ua ʻike ʻia ʻo ia ʻo arachidonoyl ethanolamide a kapa ʻia ʻo anandamide.

ʻO Anandamide kahi kokoleka?

ʻAʻole loaʻa ʻo THC i ka kokoleka. Akā, ua hoʻokaʻawale ʻia kekahi kemika, kahi neurotransmitter i kapa ʻia ʻo anandamide. ʻO ka mea e mahalo ai, hana maoli ʻia ka anandamide i ka lolo.

He cannabinoid paha ke kokoleka?

Kāhea ʻia ʻo Anandamide he endocannabinoid no ka mea hana ʻia e ko mākou kino a hoʻohālikelike i nā cannabinoids i loaʻa i ka mea kanu mariuana. No laila, hiki i kahi mea hana i ka kokoleka a me kahi mea hana i ka mea kanu mariuana ke hoʻoulu i ka ʻōnaehana neurotransmitter marijuana ponoʻī o ko mākou lolo.

Loaʻa i ka kokoleka i ka theobromine?

ʻO Theobromine ka alkaloid kumu i loaʻa i ka koko a me ke kokoleka. Hiki ke hoʻololi i ka pauka Cocoa i ka nui o kaobobine, mai ka 2% theobromine, a i ke kiʻekiʻe kiʻekiʻe ma kahi o 10%. … ʻOi aku ka nui o nā konsentrations i ka pouli ma mua o ka kokoleka waiū.

He aha nā cannabinoids maʻamau?

ʻO nā cannabinoid nui ʻelua ʻo delta-9-tetrahydrocannabinol (THC) a me cannabidiol (CBD). ʻO ka delta-9-tetrahydrocannabinol (THC) ka mea i ʻike pinepine ʻia o nā mea ʻelua, ʻo ia ka kemikona e kuleana i nā hopena psychoactive o ka cannabis.

He aha ka mole mole hauʻoli?

ʻO Anandamide kahi kemikala lolo liʻiliʻi i ʻike ʻia i kapa ʻia ʻo ka “mole mole hauʻoli” no ka hana e hana ai i ka hauʻoli. … Hana ia ma ke hoʻopaʻa ʻana i nā mea loaʻa like i ka lolo me ka compound psychoactive nui i ka mariuana.

ʻO Anandamide kahi lāʻau?

ʻO Anandamide, kahi ligand endogenous no ka lolo cannabinoid CB1 mau mea loaʻa, hana i nā hopena ʻano like ʻole e like me ka Δ9-tetrahydrocannabinol (THC), ka mea psychoactive nui i ka mariuana.

Hana paha ke kino kanaka i nā cannabinoids?

Endocannabinoids. ʻO Endocannabinoids, i kapa ʻia he endogenous cannabinoids, he mau mole i hana ʻia e kou kino. Ua like lākou me nā cannabinoids, akā hana ʻia e kou kino.

Hoʻonui ka CBD i ka dopamine?

Hoʻoikaika pū ʻo CBD i ka receptor adenosine e paipai i ka hoʻokuʻu ʻana o glutamate a me nā neurotransmitters dopamine. Ma o ka launa pū ʻana me nā receptor dopamine, kōkua ia e hāpai i nā pae dopamine a hoʻoponopono i ka ʻike, ka hoʻoikaika, a me nā ʻano ʻimi ʻimi uku.

Hoʻonui ʻo Indica i ka dopamine?

hoʻemi i ka ʻehaʻeha. hoʻonui i ka ʻai. hoʻonui i ka dopamine (kahi neurotransmitter e kōkua i ka mālama ʻana i ka uku o ka lolo a me nā kikowaena leʻaleʻa) no ka hana manawa pō.

He aha ke ʻano o ka lāʻau kokoleka?

Ma waho aʻe o ke kō, loaʻa pū kekahi i ka kokoleka i ʻelua mau lāʻau neuroactive, caffeine a me theobromine. ʻAʻole wale ka kokoleka e hoʻonāukiuki i nā mea loaʻa i ka opiate i ko mākou lolo, ʻo ia ke kumu o ka hoʻokuʻu ʻia o nā neurochemicals i nā kikowaena leʻaleʻa o ka lolo.

He aha ka hana a anandamide i ke kino?

Hoʻokumu ko mākou kino i ka anandamide ma ke koi, e hoʻohana ʻia inā pono e mālama i ka homeostasis. Hana ʻo Anandamide i kēia me ke kōkua ʻana i ka hoʻoponopono ʻana i ka mumū a me ka hōʻailona neuron. E like me ka mea i hana ʻia, paʻa paʻa mua ia me kā mākou mau pūkana cannabinoid CB1 a me CB2 e like me nā cannabinoids e like me THC i ka lawe ʻia ʻana.

He aha ka ʻōnaehana receptor cannabinoid?

ʻO nā mea loaʻa Cannabinoid, aia ma loko o ke kino, kahi ʻāpana o ka ʻōnaehana endocannabinoid, i pili i nā ʻano hanana physiological me ka makemake, ka ʻeha, ka naʻau, a me ka hoʻomanaʻo. ʻO nā mea loaʻa Cannabinoid he papa ia o nā receptor membrane cell i ka superfamily receptor protein G.

He aha nā hui hana ʻokoʻa i kēia manawa ma anandamide?

ʻO nā hui hana Anandamide e komo pū me nā amides, esters, a me nā ether o nā lālani momona polyunsaturated lōʻihi lōʻihi, a kaʻana like i nā pharmacophores koʻikoʻi me D-9-tetrahydrocannabinol (THC).

Pehea ʻoe e hoʻonui ai i nā pae anandamide kūlohelohe?

E ʻai i ka papaʻai momona i kēia mau huaʻai a kāohi i kāu hana FAAH e hoʻonui ai i kāu pae anandamide. ʻO ka kokoleka kekahi meaʻai e hiki ke kōkua i ka hoʻonui ʻana i ka anandamide. Loaʻa iā ia kahi pūhui i kapa ʻia ʻo ethylenediamine e kāpae ai i ka hana FAAH. E hoʻomanaʻo i kēia mau meaʻai ʻekolu i ka manawa aʻe āu e hele ai i ka supermarket.

Loaʻa i ka kokoleka i ka anandamide?

ʻAʻole loaʻa ʻo THC i ka kokoleka. Akā, ua hoʻokaʻawale ʻia kekahi kemika, kahi neurotransmitter i kapa ʻia ʻo anandamide. ʻO ka mea e mahalo ai, hana maoli ʻia ka anandamide i ka lolo.

ʻO ka kokoleka kahi lāʻau?

He kō ke kō he nui o ke kō. Ma waho aʻe o ke kō, loaʻa pū kekahi i nā kokoleka i ʻelua mau lāʻau neuroactive, caffeine a me theobromine. ʻAʻole wale ka kokoleka e hoʻonāukiuki i nā mea loaʻa i ka opiate i ko mākou lolo, ʻo ia ke kumu o ka hoʻokuʻu ʻia o nā neurochemicals i nā kikowaena leʻaleʻa o ka lolo.

He aha ka lāʻau i loko o ke kokoleka?

ʻO Theobromine ka alkaloid kumu i loaʻa i ka koko a me ke kokoleka.

ʻO ka kemika hea i loko o ke kokoleka?

ʻO Theobromine, i ʻike ʻia ma mua he xantheose, kahi alkaloid ʻawaʻawa o ka cacao mea kanu, me ke ʻano kemika C7H8N4O2. Loaʻa iā ia i loko o ke kokoleka, a me kekahi mau meaʻai ʻē aʻe, e like me nā lau o ka mea kanu tī, a me ka kola nut.

Hoʻonui ka kokoleka i ka serotonin?

Eia nō naʻe, no ka loaʻa ʻana o ka tryptophan i ka kokoleka, hiki i ka hoʻonui ʻia ʻana o ka serotonin ke kōkua i ka wehewehe ʻana no ke aha e hauʻoli ai kekahi, ʻoluʻolu, ai ʻole hopohopo ʻole ma hope o ka ʻai ʻana i kahi ʻāpana o kā lākou kokoleka (Serotonin).

He aha ke kuleana o ka anandamide?

He mea nui ʻo Anandamide i ke kaohi o ka hana hānai, a me ka hanauna neural o ka hoʻoikaika a me ka leʻaleʻa. Hoʻokomo pololei ʻia ʻo Anandamide i loko o ka forebrain e pili ana i ka lolo e pili ana i ka nucleus accumbens e hoʻonui i nā pane leʻaleʻa o nā ʻiole i kahi ʻono sucrose maikaʻi, a hoʻonui i ka ʻai pū kekahi.

He antioxidant anei ka CBD?

ʻO THC a me CBD he mau antioxidant mana loa-ʻoi aku ka ikaika ma mua o ka wikamina C a me E. ʻO ka ʻoiaʻiʻo, ʻo ka US Government Patent 1999/008769 no ka neuroprotectant a me nā waiwai antioxidant o nā cannabinoids.

He aha ka hana a ka FAAH enzyme?

Fatty acid amide hydrolase (FAAH) kahi mammalian integral membrane enzyme e hoʻohaʻahaʻa i ka ʻohana momona amide ʻohana o nā endogenous lipaling lipids, kahi e komo pū ana me ka endogenous cannabinoid anandamide a me ka mea hoʻomoe e hoʻomoe ai.

Pehea ka CBD i ka anandamide?

Hōʻike nā noiʻi biochemical e hiki i ka cannabidiol ke hoʻonui i ka endandamous anandamide hōʻailona hōʻailona ʻole, ma ka pale ʻana i ka hoʻohaʻahaʻa intracellular o anandamide catalyzed e ka enzyme fatty acid amide hydrolase (FAAH).

He aha ka manaʻo o ka cannabinoid?

ʻO ka huaʻōlelo cannabinoid e pili ana i kēlā me kēia mea kemikolo, me ka nānā ʻole i ke ʻano a me ke kumu, i hui pū ʻia me nā mea loaʻa lāʻau cannabinoid o ke kino a me ka lolo a he ʻano like nā hopena i hana ʻia e ka mea kanu ʻo Cannabis Sativa. … ʻO nā cannabinoid nui ʻelua ʻo delta-9-tetrahydrocannabinol (THC) a me cannabidiol (CBD).

He aha ka ʻōnaehana endocannabinoid a he aha kāna hana?

Aia i loko o ke kino o ke kanaka kahi ʻōnaehana kūikawā i kapa ʻia ka endocannabinoid ʻōnaehana (ECS), pili i ka hoʻoponopono ʻana i nā ʻano hana like ʻole me ka hiamoe, ka makemake, ka ʻeha a me ka pane ʻana o ka ʻōnaehana pale.

Loaʻa i nā kino nā mea loaʻa cannabinoid?

ʻO nā mea loaʻa Cannabinoid, aia ma loko o ke kino, kahi ʻāpana o ka ʻōnaehana endocannabinoid, i pili i nā ʻano hanana physiological me ka makemake, ka ʻeha, ka naʻau, a me ka hoʻomanaʻo. … I ka makahiki 2007, ua wehewehe ʻia ka paʻa ʻana o kekahi mau cannabinoids i ka GPR55 i loaʻa pū me ka protein G i ka lolo.

Hoʻonui ka CBD i ka anandamide?

E pili ana i ka hopena hilinaʻi o ka receptor cannabinoid o CBD ma ke aʻo ʻana i ka makaʻu makaʻu i hōʻike ʻia ma luna, hoʻonui ʻo CBD i nā pae anandamide ma o ka pāpā ʻana i kāna lawe ʻana i waena o ka lawe a me ka hoʻohaʻahaʻa ʻia e FAAH.

ʻO wai ka cannabinoid e hoʻohana ʻia no ka hopohopo?

Me kahi mahele haʻahaʻa o THC a me kahi mahele o CBD, kūpono kūpono ʻo Harlequin's cannabinoid profile no nā mea hakakā hopohopo e noʻonoʻo ʻole i ka euphoria mālie. ʻO kāna terpene nui loa ka myrcene, ka mea i manaʻo ʻia he hopena hoʻomaha a hoʻohana ʻia i loko o ka mōʻaukala ma ke ʻano he mea kōkua moe.

Kōkua ʻo CBD i ka hopohopo?

Hoʻohana mau ʻia ʻo CBD e hoʻoponopono i ka hopohopo, a no nā mea maʻi e ʻeha ma o ka pilikia o ka hiamoe, hōʻike nā noiʻi e kōkua paha ʻo CBD me ka hiamoe ʻana a me ka hiamoe ʻana. Hāʻawi paha ʻo CBD i kahi koho no ka mālama ʻana i nā ʻano ʻeha mau o ka ʻeha mau.

Kōkua ka wai ʻona i ka hopohopo?

ʻO ka waiʻona ka mea hoʻohiamoe a hoʻohaʻahaʻa e hoʻololi i ka ʻōnaehana waena. I ka manawa mua, hiki i ka inu ʻana ke hōʻemi i ka makaʻu a lawe i kou manaʻo mai kāu mau pilikia. Hiki iā ia ke kōkua iā ʻoe e hōʻemi i ka hilahila, hāʻawi iā ʻoe i ka hoʻoikaika i ka naʻau, a hoʻomaha iā ʻoe e hoʻomaha maʻamau.

Pehea wau e ʻike ai me ka hopohopo?

No ke kuhi ʻana i kahi maʻi pīhoihoi, hana ke kauka i kahi hoʻokolohua kino, nīnau e pili ana i kāu mau hōʻailona, ​​a paipai i kahi hoʻokolohua koko, e kōkua ai i ke kauka e hoʻoholo inā loaʻa kekahi maʻi, e like me hypothyroidism. E nīnau paha ke kauka e pili ana i nā lāʻau āu e lawe nei.

He aha nā lāʻau e pono ʻole e lawe ʻia me CBD?

  • Nā Antidepressants (e like me fluoxetine, a i ʻole Prozac)
  • Nā lāʻau i hiki ke hoʻoulu i ka hiamoe (antipsychotics, benzodiazepines)
  • Nā lāʻauʻalopelo Macrolide (erythromycin, clarithromycin)
  • Nā lāʻau puʻuwai (kekahi o nā blockers o ka puna calcium)

Hoʻokuʻu paha ʻo CBD i ka dopamine?

Hoʻoikaika pū ʻo CBD i ka receptor adenosine e paipai i ka hoʻokuʻu ʻana o glutamate a me nā neurotransmitters dopamine. Ma o ka launa pū ʻana me nā receptor dopamine, kōkua ia e hāpai i nā pae dopamine a hoʻoponopono i ka ʻike, ka hoʻoikaika, a me nā ʻano ʻimi ʻimi uku.

He aha ka manaʻo o ka dopamine haʻahaʻa?

ʻO kekahi o nā hōʻailona a me nā ʻōuli o nā kūlana e pili ana i ka hemahema o ka dopamine e komo pū ana me: nā ʻūʻī, nā ʻū, a me nā haʻalulu. ʻeha a me nā ʻeha. ʻoʻoleʻa i nā mākala.

Hoʻonui ka caffeine i nā pae dopamine?

ʻO Caffeine, ka mea psychoactive i hoʻohana nui ʻia i ka honua, hoʻohana ʻia e hāpai i ka makaʻala a hoʻonui i ka makaʻala. E like me nā lāʻau hoʻōla hoʻolauna ʻē aʻe (stimulants a me modafinil), hoʻonui ka caffeine i ka dopamine (DA) e hōʻailona ana i ka lolo, ka mea e hana nui ʻia e nā antagonizing adenosine A2A receptors (A2AR).

He aha ke ala wikiwiki loa e hoʻonui ai i ka dopamine?

  • ʻAi i ka Protein he nui
  • E ʻai i ka momona momona
  • Pau Probiotics
  • E ʻai i nā pīni Vvett
  • Hoʻomaʻamaʻa pinepine
  • Loaʻa i ka hiamoe nui
  • Hoʻolohe i ke mele
  • E noʻonoʻo
  • E kiʻi i ka uila
  • E noʻonoʻo i nā mea hoʻohui

Kōkua ʻo CBD i ka hopohopo?

Hoʻohana mau ʻia ʻo CBD e hoʻoponopono i ka hopohopo, a no nā mea maʻi e ʻeha ma o ka pilikia o ka hiamoe, hōʻike nā noiʻi e kōkua paha ʻo CBD me ka hiamoe ʻana a me ka hiamoe ʻana. Hāʻawi paha ʻo CBD i kahi koho no ka mālama ʻana i nā ʻano ʻeha mau o ka ʻeha mau.

Hāpai ʻo CBD i ka serotonin?

ʻAʻole pono ʻo CBD e hoʻonui i nā pae serotonin, akā e hoʻopili paha ia i ka hopena o ka hopena o ka hopena o ka lolo i ka serotonin i loko o kāu ʻōnaehana. Ua ʻike ʻia kahi noiʻi holoholona 2014 i ka hopena o CBD ma luna o kēia mau mea loaʻa i ka lolo i hana i nā hopena antidepressant a me anti-hopohopo.

Hiki iā CBD ke kōkua i kou lolo?

Manaʻo nā kānaka noiʻi he hiki i ka CBD ke hana ma ka ʻōnaehana endocannabinoid a me nā ʻōnaehana hōʻailona lolo ʻē aʻe ke hāʻawi i nā pono no ka poʻe me nā maʻi neurological. ʻO ka ʻoiaʻiʻo, ʻo kekahi o nā hoʻohana i aʻo ʻia no ka CBD i ka mālama ʻana i nā maʻi neurological e like me ka epilepsy a me nā sclerosis he nui.

Pehea e hiki ai iaʻu ke hāpai i nā pae serotonin?

  • ai
  • hoʻokō '
  • Mālamalama kukui
  • kumukanawai a
  • lomilomi
  • Hoʻokomo ʻia ka nohona

He aha ka aila CBD maikaʻi loa e kūʻai no ka pohō kaumaha?

ʻO Anandamide kahi mea waena lipid e hana ma ke ʻano he ligand endogenous o nā mea loaʻa CB1. ʻO kēia mau receptor ka pahuhopu mole molaki mua ke kuleana no ka hopena lāʻau o Δ9-tetrahydrocannabinol, ka mea psychoactive ma Cannabis sativa.

Pehea ʻoe e hana ai i ka anandamide?

Hoʻolālā ʻia ia mai ka N-arachidonoyl phosphatidylethanolamine e nā ala he nui. Hoʻohaʻahaʻa ʻia ia e ka fatty acid amide hydrolase (FAAH) enzyme, e hoʻohuli i ka anandamide i ethanolamine a me arachidonic acid.

Hana ka kino kanaka i ka CBD?

Eia naʻe ka mea āu e ʻike ʻole ai, eia kēia ma muli o ka hana maoli ʻana o ke kino o ke kanaka i kāna iho endogenous cannabinoids: kūlike kūlike o nā pūhui i loaʻa i ka mea kanu cannabis, e like me THC (tetrahydrocannabinol) a me CBD (cannabidiol).

Maikaʻi loa ʻo CBD?

ʻAʻohe mea hōʻike, no ka laʻana, hoʻōla ʻo CBD i ka maʻi ʻaʻai. Aia kahi hōʻike kūpono e hiki ai i ka CBD ke hoʻomaikaʻi i nā maʻi hiamoe, ʻeha fibromyalgia, spasticity muscle e pili ana i nā sclerosis he nui, a me ka hopohopo. "ʻO ka pōmaikaʻi nui aʻu i ʻike ai ma ke ʻano he kauka i ka mālama ʻana i nā maʻi hiamoe, ka hopohopo, a me ka ʻeha," wahi a Kauka Levy.

Palekana anei nā huahana CBD?

Hāpai kekahi ʻo CBD i kekahi mau pilikia. ʻOiai ʻoluʻolu maikaʻi ʻia ia, hiki i ka CBD ke hana i nā hopena ʻaoʻao, e like me ka waha maloʻo, ka palahū, hoʻoliʻiliʻi ka makemake, ka hiamoe a me ka luhi. Hiki i ka CBD ke launa pū me nā lāʻau ʻē aʻe āu e lawe nei, e like me nā mea hōʻemi koko.

He aha ka hana a CBD i ka lolo?

Pili kēia mau ʻano i ka hiki i ka CBD ke hana ma nā mea loaʻa o ka lolo no ka serotonin, kahi neurotransmitter e hoʻoponopono ana i ka naʻau a me ka nohona kanaka. Hōʻuluʻulu Manaʻo ʻana e hōʻike ana i ka CBD e hōʻemi i ka hopohopo a me ke kaumaha i loko o nā kānaka a me nā holoholona.

Pehea ka wikiwiki o ka haʻalele ʻana o CBD i ka ʻōnaehana?

Noho mau ʻo CBD i kāu ʻōnaehana no 2 a 5 mau lā, akā ʻaʻole pili kēlā pae i nā mea āpau. No kekahi, hiki i ka CBD ke noho i loko o kā lākou ʻōnaehana no mau pule.

Aia ma hea kahi anandamide?

Hoʻokomo ʻia ʻo Anandamide i kahi enzymatically i nā wahi o ka lolo i mea nui i ka hoʻomanaʻo, nā hana noʻonoʻo a me ka kaohi o ka neʻe. Hōʻike ka noiʻi e hana nui ka anandamide i ka hana a me ka haki ʻana o nā pilina wā pōkole ma waena o nā pūnaewele nerve, a pili kēia i ke aʻo ʻana a me ka hoʻomanaʻo

ʻO Anandamide kahi cannabinoid?

Kapa pū ʻia ʻo N-arachidonoylethanolamine (AEA), hui pū ʻo anandamide me nā receptor CB o ke kino e like me nā cannabinoids e like me THC. He neurotransmitter a me ka mea hoʻopaʻa paʻa hiki i ka cannabinoid-receptor e hana nei ma ke ʻano he elele hōʻailona no nā mea loaʻa CB i loko o ke kino.

Pehea e holo ai ʻo Anandamide (AEA)

Loaʻa ka Anandamide (AEA) mai ka non-oxidative metabolism o ka eicosatetraenoic acid. ʻO Anandamide (AEA) kahi mea waena lipid a me nā hana ma ke ʻano he ligand endogenous o nā CB1 receptor a hoʻololi i kāna huakaʻi uku. He neurotransmitter koʻikoʻi ia i loko o ka ʻōnaehana endocannabinoid, i kapa ʻia ma hope o Cannabis. Kōkua ia i ka hoʻoponopono ʻana i ke kahe o nā ʻōnaehana neurochemical e mālama pono i kou kino a me kou noʻonoʻo. ʻIke ʻia he ʻano like ke ʻano Anandamide me tetrahydrocannabinol (THC), ka mea psychotic nui o Cannabis. Pēlā ʻo Anandamide e loli ai i ke ʻano simulate i ka mea i ʻike nui ʻia ʻo Cannabis kiʻekiʻe.

Hana maoli ʻia ia i loko o kā mākou kino e like me ke aʻo ʻana o ka lolo e ka hopena condensation i nā neurons. ʻO ka hopena condensation e kāohi ʻia e ka sodium calcium a me ka cyclic monophosphate adenosine e hana ʻia ma waena o ka acid arachidonic a me ka ethanolamine.

Hoʻonui ʻo Anandamide i ka hauʻoli ma o ka launa pū ʻana me nā mea loaʻa cannabinoid i loko o ka ʻōnaehana hopohopo a me nā ʻōiwi, CB1 a me CB2. Hoʻokumu nā mea loaʻa CB1 i ka hana moto (neʻe) a me ka hoʻohui ʻana, ka noʻonoʻo ʻana, ka makemake, ka hoʻomanaʻo pōkole, ka ʻike ʻeha, a me ka palekana. I ka manawa like, hoʻokūkū nā mea loaʻa CB2 i nā mea nui e like me ka Liver, Gut, kidney, Pancreas, nāʻaʻaʻa Adipose, nā ʻiwi iwi, ka iwi, ka maka, nā tumors, ka ʻōnaehana, nā ʻōnaehana Immune, nā ʻōnaehana Respiratory, ka ʻili, ka ʻōnaehana Nervous Central, a me ka ʻōnaehana Cardiovascular. .

I loko o ko mākou kino, N-arachidonoylethanolamine e haki i loko o ka fatty acid amide hydrolase (FAAH) enzyme a hana i ka acid arachidonic a me ka ethanolamine. Inā hiki ke hoʻolōʻihi ʻia ka hana a FAAH'sFAAH, hiki iā mākou ke ʻohi i nā pono o Anandamide'sAnandamide no kahi wā lōʻihi.

Anandamide (AEA)
Anandamide (AEA)

Pehea e holo ai ʻo Cannabidiol (CBD)?

Aia i loko o ko mākou kino kahi ʻōnaehana kūikawā i kapa ʻia ka ʻōnaehana endocannabinoid kuleana no nā loli physiological. Hoʻokumu ke kino i nā endocannabinoids ma kāna iho. ʻO ka endocannabinoid nā neurotransmitters e hoʻopaʻa ai i nā mea loaʻa cannabinoid.

Aia he ʻelua mau mea lawe ʻai cannabinoid; Nā mea loaʻa CB1 a me CB2. Loaʻa nā mea loaʻa CB1 ma loko o ke kino a ma ka lolo hoʻi. Kaohi lākou i kou naʻau, manaʻo, neʻe, makemake, hoʻomanaʻo, a me ka noʻonoʻo.

Loaʻa nā mea loaʻa CB 2 ma ka ʻaoʻao ʻē aʻe i ka ʻōnaehana pale a hoʻoulu i ka mumū a me ka ʻeha.

ʻOiai paʻa paʻa ʻo THC i nā mea loaʻa CB1, ʻaʻole paʻa paʻa ʻo CBD i nā mea loaʻa akā hoʻonāukiuki i ke kino e hana i nā endocannabinoids hou aʻe. Hiki i ka CBD ke hoʻopaʻa a hoʻohana paha i nā mea loaʻa ʻē aʻe e like me ka receptor serotonin, vanilloid, a me nā PPAR [peroxisome proliferator-activated activated] nā mea loaʻa. Hana ʻo CBD ma ke ʻano he antagonist i nā GPR55-orephan receptor.

Hoʻopili ʻo CBD i ka reseptor serotonin i hoʻopili ʻia i ka hopohopo, hiamoe, ʻike i ka ʻeha, makemake, nausea, a me ka luaʻi.

Hoʻopili pū ʻo CBD i ka receptor vanilloid i ʻike ʻia e hoʻopōkā i ka ʻeha, ka wela, a me ka mahana o ke kino.

Hana ʻo CBD ma ke ʻano he antagonist i ka receptor GPR55 e hōʻike pinepine ʻia i nā ʻano maʻi ʻaʻai like ʻole.

Hana pū ʻo Cannabidiol ma ke ʻano he agena anti-inflammatory. E hakakā a hoʻomāmā paha i ka mumū.

Loaʻa iā Cannabidiol nā waiwai antioxidant e hiki ai iā ia ke hoʻopau i nā radical manuahi e pili pinepine ʻia me nā maʻi degenerative.

Loaʻa maikaʻi ʻo Anandamide (AEA)

Hoʻohālikelike ʻo Anandamide (AEA) i nā hopena o Cannabis ma kā mākou ʻōnaehana, me ka ʻole o nā hopena maikaʻi ʻole. Kōkua ʻo Anandamide iā mākou ma ka hoʻoulu ʻana i ka hana o ka lolo i nā ala aʻe:

Anandamide (AEA)

H Hoʻonui i ka hiki i ka lolo a me ka hoʻomanaʻo

ʻO ka hoʻonui ʻana i kou hiki i ka hoʻomanaʻo ʻana ka hana nui Loaʻa maikaʻi ʻo Anandamide (AEA). Kōkua pū ia iā ʻoe e lilo i mea hana hou aʻe ma o ka hana ʻana i ka ʻike i nā manaʻo hou. Ua hōʻike kahi noiʻi i nāʻiole i ka hoʻomaikaʻi nui ʻana i ka hana o ka lolo. Pēlā inā makemake ʻoe e hoʻomaikaʻi i kāu mākau anamanaʻo, nā mākau hana, a hana maikaʻi paha i kāu mau aʻo ʻana, ʻo Anandamide ka hopena kūpono.

② Hana ma ke ʻano he mea mālama i ka makemake

Inā makemake ʻoe e hāhai i ka papaʻai koʻikoʻi, pono ka mālama ʻana i ka makemake. ʻO kekahi o nā pono Anandamide hiki iā ia ke kōkua iā ʻoe e kaohi i ka makemake a me nā pōʻaiapuni satiety. Hiki iā ʻoe ke kāohi maʻalahi i nā maka o ka pōloli a i ʻole kuko no ka ʻōpala me ke kōkua o Anandamide. ʻO kēia ala, hiki iā ʻoe ke hoʻokō i kāu pahuhopu kaumaha o ke kaupaona a i ʻole nā ​​pahuhopu o ka loaʻa hou ʻana o ke kinona. I nā lā hou e noho ana i ke olakino a kūpono i ka hilinaʻi nui i kā mākou ʻano maʻamau o ka meaʻai, a hiki i nā mea kōkua Anandamide ke kōkua iā mākou. Akā ʻo nā hoʻolālā hōʻemi kaumaha me Anandamide e pono e hoʻokō ʻia me nā hoʻolālā papaʻai kūpono. Hiki i ka undereating koʻikoʻi ke alakaʻi i ka lilo koke o ke kaumaha o ke kino a, no laila, nā pilikia metabolic. Eia kekahi, i ka hihia o nā makuahine lactating, pono e hōʻalo i ka ʻai Anandamide. (5)(2015). Cannabidiol (CBD) a me kāna mau analogs: kahi loiloi i ko lākou hopena ma ka lī.

③ Neurogenesis

ʻO kahi ala e hoʻonui ai i kāu hana lolo ka loaʻa ʻana o nā neurons hou a i ʻole nā ​​pūnaewele lolo ma o Neurogenesis. He ʻoiaʻiʻo kēia, ke neʻe nei ʻoe i 40 a i ʻole ua hala ma mua o ka makahiki. Kōkua ʻo Anandamide (AEA) ma Neurogenesis.

Eia kekahi, ʻo nā pae kiʻekiʻe o nā Anandamide i loko o ke kino o ke kanaka e hoʻopau i nā makaʻu o nā maʻi neurodegenerative e like me ka maʻi ʻo Perkinson'serkerkinson, a pēlā aku. ke kino, a pēlā aku. Anandamide (AEA) kōkua i nā mākua makua e hauʻoli i ko lākou ola hoʻomaha me ka hopohopo ʻole e pili ana i nā pilikia olakino.

Anandamide (AEA)

④ Ke kāohi nei i nā makemake moekolohe

Anandamide (AEA) pono ke kāohi i kou makemake moekolohe i ʻelua ala. I nā mea maʻa mau, hoʻonui ia i nā makemake moekolohe. Akā me ka mahele nui o Anandamide (AEA) e hoʻēmi i ka makemake moekolohe. Hoʻomaikaʻi ʻo Anandamide (AEA) i kou ʻano a hōʻoluʻolu i ke koʻikoʻi e hāpai ana i ka makemake moekolohe. Akā ʻo kahi mahele lāʻau kiʻekiʻe e hōʻoluʻolu iā ʻoe i ka moekolohe, a ʻike ʻole ʻoe i kahi pono no ka moekolohe.

Anandamide (AEA)

⑤ Nā anti-Cancer waiwai

Loaʻa ka Anandamide (AEA) i nā waiwai ant carcinogenic ma o nā hopena psychotropic. Kūʻē ʻo Anandamide (AEA) i ka ulu maʻi maʻi maʻi maʻi maʻi. He mea maikaʻi loa ia i ka maʻi ʻaʻai umauma. Ke hōʻike nei nā hoʻokolohua hiki ke lilo i pani maikaʻi no nā lāʻau maʻamau o ka maʻi ʻaʻai. Eia kekahi, ʻaʻohe ona hopena i hoʻohālikelike ʻia i nā hopena hoʻololi o ke ola o nā lāʻau ʻaʻai maʻamau. No laila i ka manawa pōkole, ʻo ka ʻae ʻia nui o Anandamide (AEA) e hōʻemi paha i ka ʻeha a nā mea maʻi maʻi maʻi i hele ai i ka wā o ka mālama ʻana.

Nā waiwai antiemetic

Hiki ke kāohi pū ʻia ʻo Nusea a me ka luaʻi me Anandamide (AEA). Hana ia me ka serotonin e kaohi i ka nausea. Hana kēia iā Anandamide (AEA) i kahi hopena antiemetic i ka wā chemotherapy ma nā mea maʻi maʻi maʻi. Hiki ke maikaʻi kēia no nā makuahine hāpai pū kekahi. Akā i ka hihia o nā makuahine hāpai, pono e hana ʻo Anandamide (AEA) inā e koi ʻia e kāna kauka.

⑦ Nā mea kōkua ʻeha

Ma ka hoʻopaʻa ʻana me CB1, Anandamide (AEA) ālai i ka lawe ʻia ʻana o nā hōʻailona ʻeha. ʻO kēia ala, Anandamide (AEA) hiki ke hoʻohana ʻia no ka hōʻeha ʻeha mau loa i nā mea maʻi e ʻeha ana i nā kūlana olakino e like me ka gout, arthritis, a sciatica paha. I nā makahiki ʻelemakule, he hoa hele mau ka ʻeha. ʻO Anandamide (AEA) kahi lāʻau i hōʻoia ʻia no ka migraines a me nā maʻi poʻo ʻeha ʻē aʻe. ʻO ka hoʻohana ʻana i nā mea kōkua Anandamide (AEA) i ka wā ʻelemakule e kōkua iā lākou e lanakila i ka ʻeha a hoʻomaikaʻi hoʻi i ko lākou ola.

Anandamide (AEA)

⑧ Hoʻoponopono Mood

Mālama ka ʻōnaehana endocannabinoid i ko mākou ʻano. Anandamide (AEA) kaohi i ko mākou manaʻo noʻonoʻo maikaʻi ʻole e like me ka makaʻu, hopohopo, a hoʻonui i ka hauʻoli. ʻO kēia ala, Anandamide (AEA) hiki ke hana ma ke ʻano he mea hāpai i ka naʻau, hoʻomaikaʻi i ke olakino noʻonoʻo, a hoʻomaikaʻi i kou kino i loko. ʻOiai ʻo Anandamide (AEA) mau mea hoʻopihapiha ʻaʻole mea hōʻalo, koi nui ʻia ia, ʻo ia hoʻi no ka heluna makahiki o ka makahiki hana, e pono ai e hoʻomau i ka hana me ka hana kiʻekiʻe i kahi wahi koi a koʻikoʻi hoʻi.

Anandamide (AEA)

E hakakā i ke kaumaha

Anandamide (AEA) hiki ke kaua aku hoʻi kaumaha. Ua hōʻoia ʻia kahi noiʻi ma nā ʻiole i kāna mau ʻano antidepressant. ʻO ke kaumaha a me nā pilikia e pili ana ke lawe nui nei i ko mākou olakino a me ke olakino ... ʻoiai i ko mākou kaiāulu. Hoʻopili pinepine i ka nikotine, ʻalekohola, hoʻohana lāʻau ʻino me ke kaumaha. ʻO nā kūlana ʻoi loa paha ke alakaʻi i ka poʻe e lawe i ko lākou ola. Hiki i ke kaumaha ke lilo i mea hōʻemi maikaʻi ʻole e hiki ai ke alakaʻi i ka poʻe i ka make. Hiki i ka Anandamide (AEA) ke lilo i hopena maikaʻi loa i kēia pilikia.

⑩ Nā hakakā a me ka ʻōpala

Hoʻoemi ka Anandamide (AEA) i ka pehu a me ka edema o ka cell. ʻO kēia ala, pono ia ma ke ʻano he hopena anti-inflammatory.

NāʻAla'ē aʻe

Hiki i ka Anandamide (AEA) ke pāʻani i kahi kuleana kūpono i ka ovulation a me ka implantation. Hōʻike nā haʻawina i nā kiʻekiʻe Anandamide (AEA) kiʻekiʻe e hōʻoia i ka holomua holomua.

Ma mua o 60% o ka poʻe e hoʻomohala i ka hypertension a i ʻole nā ​​maʻi maʻi maʻi mau. Hiki iā Anandamide (AEA) ke hoʻololi i nā hana hakuʻala e kumu ai ka maʻi. Ua hōʻike ʻo Anandamide (AEA) i nā hopena maikaʻi i ka hoʻonā ʻana i nā pilikia i hoʻokumu ʻia e ke kiʻekiʻe o ke koko.

Anandamide (AEA) Nā Kumuwaiwai Kūlohelohe

i. Black Truffles (ʻeleʻele fungi)

Aia nā Black Truffles i ka Anandamide maoli.

ii. Keahi a me nā mea kanu

Cannabis, cloves, cinnamon, black pepper, oregano, etc. hoʻomaikaʻi i nā pae Anandamide i loko o kā mākou kino. He kumu maikaʻi loa ʻo Tea o Anandamide (AEA).

iii. kokoleka

ʻO ka kokoleka pouli kekahi o nā kumu waiwai ʻoi o Anandamide. Hana ʻia ka pauka Cocoa o ka oleolethanolamine a me ka linoleoylethanolamine. ʻO ka haʻahaʻa o ka haki ʻana o endocannabinoids a pēlā e mālama ai i nā pae Anandamide i loko o kā mākou kino. Eia kekahi, aia i ka kokoleka ka theobromine, i kōkua i ka hana Anandamide.

iv. ʻO nā wai momona momona

ʻO nā hua manu, nā hua Chia, nā hua flax, sardine, nā hua hemp kahi waiwai nui o endocannabinoid e hoʻonui ana i nā waikawa momona. Ma ka huli, hoʻomaikaʻi kēia i ka pae o ka Omega 3 a me ka Omega 6 i ko mākou kino e hoʻomaikaʻi i ka hana endocannabinoid.

Anandamide (AEA) nā mea hoʻopili a me nā ala ʻē aʻe e hoʻomaikaʻi ai i nā pae Anandamide

CBD (Cannabidiol)

ʻO kekahi o nā ala maikaʻi loa e hoʻoulu ai i ka ʻōnaehana endocannabinoid ʻo ia ka ʻai ʻana o CBD. ʻO CBD ke kumu nui o ka pakalōlō lapaʻau. Hoʻopili ka CBD iā FAAH a hoʻomaikaʻi i nā pae Anandamide i loko o kā mākou kino.

hoʻokō '

Lawe ka hoʻoikaika i kahi mea maikaʻi i loko o mākou. Hoʻonui ka hoʻomaʻamaʻa i nā pae Anandamide i loko o ke kino a no laila hoʻonui i kou ʻano e hoʻoikaika ikaika. Hōʻike nā hoʻokolohua ma hope o ka hoʻoikaika kino, lilo lākou i mālie a pale i ka ʻeha. Manaʻo ʻia kēia ma muli o ka hoʻoulu ʻia ʻana e Anandamide e CB1 a me CB2'sCB2. ʻIke ʻia he 30 mau minuke o ka holo ikaika ʻana a i ʻole nā ​​aerobics e hoʻonui nui i nā pae Anandamide i loko o kā mākou kino. ʻIke ʻia nō hoʻi nā mea maʻi migraines e lawe i nā aerobics e mālama hou i ka mea like. ʻO ia ma muli o nā kiʻekiʻe o Anandamide i hana ʻia i ko lākou kino ma muli o ka hana nui.

ʻO ke kaumaha ʻO ke kaumaha

ʻO ka poʻe hiki ke kaohi i ke koʻikoʻi ke kiʻekiʻe o Anandamide i loko o lākou. Hoʻoemi ka pilikia i ka hopena o nā mea loaʻa CB1 a pēlā e hōʻemi ai i nā pae o Anandamide a, a laila, hōʻike i ka hoʻemi ʻia o ka hana cannabinoid. Pēlā e hōʻalo ai i nā hanana pilikia e hoʻomaikaʻi ai i ke ola holoʻokoʻa. ʻO kekahi o ia ʻano hopena ʻo ka noʻonoʻo. Hoʻomaikaʻi ka hoʻohui i nā pae Anandamide a me nā dopamine i loko o kā mākou kino. Mediatbodiesleads i ke kiʻekiʻe o ka oxytocin e hoʻonui hou ai i nā pae Anandamide i loko o kā mākou kino. He like ia me kahi pōʻai maikaʻi o ke ola maikaʻi. Kōkua ʻo Anandamide iā ʻoe e hoʻomālie a noʻonoʻo; hoʻonui ka noʻonoʻo ʻana i kāu pae Anandamide a kōkua iā ʻoe e hōʻoluʻolu mai ke koʻikoʻi.

Hana Anandamide (AEA)

E like me nā endocannabinoids ʻē aʻe, maikaʻi ke ana o waho o Anandamide no mākou. ʻO nā lāʻau kiʻekiʻe ke hoʻopōʻino i ko mākou kino. 1.0mg / kg. (no Kg o ke kaumaha o ke kino) kūpononā huahana o Anandamide (AEA). Akā inā ʻoe e ʻike i kekahi pilikia, pono ʻoe e nīnau koke i ke kauka. I nā makuahine hāpai a me nā makuwahine e hānai ana i ka waiū pono lākou e nīnau i kā lākou kauka ma mua o Anandamide (AEA) hoʻohana.

Nā hopena ʻaoʻao ʻo Anandamide (AEA)

He ahonui kiʻekiʻe ʻo Anandamide a me nā hopena ʻaoʻao haʻahaʻa. Hiki paha iā ʻoe ke ʻike i kekahi mau pilikia kūlohelohe e like me ka lilo ʻana o ke kaupaona, dizziness, a i ʻole ka luaʻi. I kekahi mau hihia, ʻo ka Anandamide (AEA) hoʻomalu i ka wā o ka hānai ʻana (i aʻo ʻia i nā ʻiole makua) hiki i ke kaupaona ʻana, ka hōʻiliʻili momona o ke kino, a me ke kūpaʻa o ka insulin. Hana kēia ma muli o ka hoʻonui ʻana o ka makemake e alakaʻi i ka ʻai nui.

Kūʻai i nā mea kōkua Anandamide (AEA)

Hiki iā mākou ke hoʻomaopopo maʻalahi i ke ola olakino Anandamide (AEA) pono. Kōkua ia i ka pale ʻana a me ka hakakā ʻana i nā ʻano maʻi like ʻole. I mea e hōʻalo ai i ka hemahema ʻo Anandamide (AEA), he mea naʻauao e hoʻopau i nā mea hoʻopihapiha i nā lāʻau i kuhikuhi ʻia. ʻO ka maʻamau, loaʻa ʻo Anandamide (AEA) i ka aila (70% a me 90%) a me nā ʻano Powder (50%). Ua lilo ʻo Kina i mea hana nui i Pākuʻi Anandamide (AEA).

Cannabidiol (CBD) hoʻohana

ʻO nā mea aʻe ka hoʻohana ʻia ʻana o ka cannabidiol;

● Ke mālama ʻana i ka maʻi hopu (epilepsy)

Hoʻohana ʻia ʻo Cannabidiol e mālama i ka hopu ʻana. Hiki i ka CBD ke hoʻololi i nā kaha sodium o ke aʻa nerve. ʻO kahi mea koʻikoʻi i ka epilepsy ka neʻe maʻamau o ka sodium i loko a i waho o nā hunaola. ʻO kēia ke kumu o ka lolo e kī i ke ahi e alakaʻi maʻamau i ka hopu ʻana. Ua loaʻa ʻo CBD e hōʻemi i kēia kahe maʻamau o ka sodium no laila e hōʻemi i ka hopu ʻana.

Ua ʻae ʻia kekahi mau huahana CBD e like me Epidiolex no ka mālama ʻana i nā maʻi hopu a Lennox-Gastaut Syndrome, Dravet Syndrome, a i ʻole tuber sclerosis complex. Hoʻohana pū ʻia kēia lāʻau lapaʻau me nā lāʻau anti-seizure ʻē aʻe e mālama ai i ka hopu ʻana i ka poʻe e loaʻa ana i ka maʻi Sturge-Weber, ka maʻi maʻi epilepsy e pili ana i ka maʻi febrile, a me kekahi mau maʻi kūlohelohe e hoʻopiʻi ana i ka epileptic encephalopathy.

I loko o kahi noi 2016 e pili ana i 214 mau kānaka e ʻeha nei i ka maʻi epilepsy, lawelawe ʻia ʻo CBD ma 2 a 5 mg i kēlā me kēia lā no 12 mau pule me ka hoʻohui ʻia o ka lāʻau epilepsy. Ua ʻike ʻia he ʻoi aku ka hopu ʻana o ka poʻe komo i kēlā me kēia mahina.

● Hiki ke hoʻohana ʻia i ka mālama ʻana i ka maʻi ʻaʻai

Hiki ke hoʻohana ʻia ka aila Cannabidiol e hōʻemi i nā ʻōuli e pili ana i ka maʻi ʻaʻai a me nā hopena ʻē aʻe o ka mālama ʻana i ka maʻi ʻaʻa e like me ka ʻeha, nausea, a me ka luaʻi.

I ke aʻo ʻana o 16 mau maʻi ʻaʻai e hele ana i ka chemotherapy, ua hoʻohana ʻia ʻo CBD me THC e hōʻemi i nā hopena e pili ana i ka chemotherapy e like me ka nausea a me ka luaʻi.

Ua hōʻike ʻia kahi noiʻi ʻē aʻe ua kāohi maikaʻi ʻo CBD i ka ulu ʻana o ka maʻi ʻaʻai umauma i nāʻiole.

● Hōʻike i nā pono neuroprotective

Ka hiki i ka CBD ke hoʻohuli i ka ʻōnaehana endocannabinoid a me nā ʻōnaehana hōʻailona lolo ʻē aʻe i mea maikaʻi i nā poʻe me nā maʻi neurological. Hiki i ka aila CBD ke hōʻemi i ka līlū e pili pū me nā maʻi neurodegenerative.

Ua nānā ka hapa nui o nā noiʻi i ka hoʻohana ʻana o CBD i ka mālama ʻana i nā maʻi neurological e like me ka epilepsy a me nā sclerosis he nui. Hōʻike ka noiʻi i ka hiki ke hoʻohana ʻia i ka mālama ʻana i nā maʻi ʻē aʻe e like me ka maʻi Alzheimer a me ka maʻi ʻo Parkinson.

I kahi loiloi lōʻihi o nā ʻiole i hōʻike mua ʻia i ka maʻi o Alzheimer, ua loaʻa ʻo CBD e pale aku i ka emi ʻana o ka ʻike.

● Ke mālama ʻana i ka maʻi diabetes 1

ʻAno 1 diabetes he ʻano o ka maʻi diabetic e kū i ka wā e pale ai ka ʻōnaehana pale i nā hunaola i ka pancreas, hopena kēia i ka puhū.

Ua loaʻa ʻo CBD i nā ʻano anti-inflammatory, no laila e hōʻoluʻolu paha ia i ka lī ʻana a hoʻolohi paha i ka loaʻa ʻana o ka maʻi diabetes type 1.

I ke aʻo ʻana i nā ʻiole me ka maʻi kō, ua loaʻa ʻo CBD e pale aku i nā neurons e ka pale ʻana i ka emi o ka naʻau a me ka hōʻemi ʻana i ka mumū nerve.

Nā pono ʻo Cannabidiol (CBD)

He laulā ka nui o nā pono kōkua he Cannabidiol.
Ma lalo iho nei kekahi o nā pono cannabidiol;

● Hiki ke hōʻemi i ka hopohopo a me ke kaumaha

Hiki iā Cannabidiol (CBD) ke kōkua i ka hōʻemi ʻana i ka hopohopo a me ka hoʻoliʻiliʻi ʻana i kekahi ʻano e pili ana i ka hopohopo e pili ana i nā kūlana e like me ka maʻi o ka hopohopo nui, nā maʻi panic, nā maʻi ʻōiwi, a me nā maʻi stress post-traumatic (PTSD).

I ke aʻo ʻana i nāʻiole, ʻike ʻia ka cannabidiol e hōʻike i nā hopena anti-hopohopo a me nā antidepressant.

● Hiki ke hōʻoluʻolu i ka ʻeha

Hāʻawi ʻo CBD i kahi hōʻeha ʻeha kūlohelohe ma mua o nā lāʻau lapaʻau maʻamau.

Aia i loko o kā mākou kino kahi ʻōnaehana endocannabinoid loea i kuleana no ka hoʻoponopono ʻana i ka hiamoe, ʻeha, ka puhū, a me ka pane ʻana o ka ʻōnaehana pale. Pēlā e hoʻopuka ai ke kino i nā endocannabinoids, nā neurotransmitters e hoʻopili i nā mea loaʻa cannabinoid i kāu ʻōnaehana hopohopo.

Ua hōʻike ʻia ʻo CBD i ka hopena o ka ʻōnaehana endocannabinoid a pēlā e hōʻemi ai i ka ʻeha a me ka mumū.

I ka hui pū ʻana me THC, hiki ke hoʻohana ʻia ka aila CBD e mālama i ka ʻeha e pili ana i nā ʻano like ʻole e like me nā sclerosis he nui, ka maʻi pākī, ʻehaʻeha sciatic, a me nā ʻeha o ke kuamoʻo.

I ke aʻo ʻana i ka poʻe e ʻeha nei i ka rheumatoid arthritis, CBD i hoʻohana pū ʻia me THC i loaʻa e hōʻoluʻolu nui i ka ʻeha i ka neʻe ʻana a me ka hoʻomaha a me ka maikaʻi o ka hiamoe o nā mea maʻi.

● Hiki ke hōʻemi i ka huehue

ʻO ka huehue kahi maʻi ʻili e pili i nā poʻe he nui. Ma muli paha o nā genetics, ka puhū ʻana, a me ka hana nui ʻana o ka sebum (kahi mea aila i hana ʻia e nā sebaceous glands i ka ʻili).

Hōʻike ka noiʻi e hiki i ka CBD ke kōkua i ka hōʻemi ʻana i ka huehue ma ka hana ʻana ma ke ʻano he anti-inflammatory agents a me ka hoʻēmi ʻana i ka hana sebum.

Eia kekahi laʻana, ua ʻike ʻia kahi noiʻi kanaka ua hiki i ka aila CBD ke pale aku i ka hana nui ʻole ʻana o ka sebum e nā gland sebaceous no laila he lapaʻau maikaʻi o ka huehue.

● Hiki ke kōkua i ka haʻalele ʻana i ka puhipaka a me ka haʻalele ʻana i ka lāʻau

Hiki i ka CBD ma ke ʻano he inhaler ke kōkua i ka poʻe puhipaka e hoʻohana i nā uahi ʻuʻuku a me ka hōʻemi ʻana i kā lākou hōʻalo i ka nikotine. He mea nui kēia i ke kōkua ʻana i kekahi e haʻalele i ka puhipaka.

I loko o kahi noi ma 2018 ua kaulana ʻo CBD e kōkua i ka hoʻohaʻahaʻa ʻana i ka makemake no ka paka ma hope o ka haʻalele ʻana. Ua loaʻa e kōkua i kekahi e noho nanea.

Hiki iā Cannabidiol (CBD) ke hāʻawi i nā keu pono ʻē aʻe e like me;

  • Hiki ke kōkua i ka poʻe me ka hiamoe ʻole e loaʻa ka maikaʻi a me ka hiamoe pau ʻole
  • Hiki iā ʻoe ke hoʻokuʻu iā ʻoe mai ka headache a i ʻole migraine,
  • Hiki iā ia ke kōkua i ka hōʻemi ʻana i ka nausea,
  • Hiki ke kōkua i ke kōkua i nā maʻi āpau a i ʻole ka hānō
  • Hiki ke hoʻohana ʻia i ka mālama ʻana i nā kūlana māmā.

Cannabidiol (CBD) mahele lāʻau

Kau ʻia ka wana aila Cannabidiol i ke ʻano o ka hoʻokele, ke kumu i manaʻo ʻia, ka makahiki, a me nā ʻano kumu ʻē aʻe. Inā makemake ʻoe e hoʻohana i ka aila cannabidiol pono ʻoe e nīnau i kāu kauka pehea e lawe ai i ka aila CBD ma mua o ka loaʻa ʻana iā ia no ka ʻōlelo aʻoaʻo ʻoihana e pili ana i ka hoʻohana kūpono a me nā mea hana. Pehea e lawe ai i ka aila CBD e kaukaʻi ʻia i ke ʻano o ka hoʻoponopono ʻana e like me;

  • Lawe ʻia ka papa a me nā capsule i ka waha a i ʻole ka sublingally
  • Lawe waha ʻia ka ʻaila Cbd
  • ʻAila Cbd no ka noi ʻana ma ka ʻili
  • Nasal sprays no ka hanu ʻana

ʻOiai he mea hou loa ka cannabidiol ʻaʻohe mea maʻamau no nā ʻano hana like ʻole. Eia naʻe, ua ʻae ka FDA i ka hoʻohana ʻana o Epidiolex, kahi o nā huahana i loaʻa i ka cannabis. Ua ʻae ʻia no ka mālama ʻana i ka epilepsy koʻikoʻi i hoʻokumu ʻia e Dravet Syndrome a i ʻole Lennox-Gastaut Syndrome.

ʻO ke ana i koi ʻia no Epidiolex penei:

  • ʻO ka mahele hoʻomaka he 2.5 mg / Kg o ke kaumaha o ke kino i lawe ʻia i ʻelua mau manawa i kēlā me kēia lā, e hana ana i ka nui o nā ana o 5 mg / kg i kēlā me kēia lā.
  • Ma hope o 1 pule, hoʻonui ʻia paha ka lāʻau i 5 mg / kg i ʻelua mau lā i kēlā me kēia lā, ʻo ia ka nui o 10 mg / kg i kēlā me kēia lā.

ʻOiai ʻo ka nui o nā pono aila CBD i hoʻopaʻa ʻia e ʻike paha kekahi i kekahi hopena hopena cannabidiol e like me ka nausea, ka luhi, ka maʻi palahēhē, ka pau ʻole o ka makemake, a me ka huhū.

Cannabidiol (CBD) no ke kūʻai aku (Buy Cannabidiol (CBD) i ka nui)

Loaʻa koke ka ʻaila Cannabidiol no ka kūʻai aku ma ka pūnaewele. Eia nō naʻe, ke noʻonoʻo ʻoe i ka cannabidiol e kūʻai iā ia mai kahi kumu hilinaʻi i ʻae ʻia no ke kūʻai aku o ka ʻaila cannabidiol e loaʻa ai ka aila CBD maikaʻi loa.

Hiki iā ʻoe ke nānā no nā loiloi o nā mea kūʻai aku ma ka hapanui o nā pūnaewele e ʻike i ka mea hoʻolako huahana CBD hilinaʻi e hāʻawi nei i ka aila CBD maikaʻi loa.

Kūʻai mau i ka cannabidiol (CBD) i ka nui e hauʻoli i nā kumukūʻai i hōʻemi ʻia.

E hāhai i nā ʻōkuhi pehea e lawe pono ai i ka aila CBD e hōʻalo ai i ka ʻike ʻana i nā hopena maikaʻi ʻole o ka aila CBD.

Kahi e kūʻai i ka paukū Anandamide (AEA) i ka nui

ʻO Cofttek   huahana

Kukulu ʻia i ka makahiki 2008, ʻo Cofttek kahi ʻoihana Hoʻohui Dietiko ʻenehana kiʻekiʻe mai Luohe City, Henan Province, Kina.

Pūʻolo: 25kg / pahu

Lana ka manaʻo e kōkua kēia !! He aha kāu mea e kali ai i kēlā manawa? E kiʻi iā Anandamide home a hoʻomaikaʻi i ke ola!

Paukū e : ʻO Dr. Zeng

Paukū ma:

ʻO Kauka Zeng

Co-hoʻokumu, alakaʻi alakaʻi o ka ʻoihana o ka ʻoihana; Loaʻa ʻo PhD mai ke Kulanui ʻo Fudan i ka kemika kemika. Ma mua o ʻeiwa mau makahiki o ka ʻike i ke kemika kemika a me ka synthesis hoʻolālā lāʻau; ʻaneʻane 10 mau pepa noiʻi i paʻi ʻia i loko o nā puke pai mana, me ʻoi aku o ʻelima mau Sila Nui Kina.

E hoʻomaopopo '

(1) .Mallet PE, Beninger RJ (1996). "ʻO ka endogenous cannabinoid receptor agonist anandamide hoʻopilikia i ka hoʻomanaʻo i nāʻiole". ʻOihana Pharmacology. 7 (3): 276–284

(2). Mekhoulam R, Fride E (1995). "Ke ala helehelena ʻole i ka hopena o ka lolo cannabinoid lolo, nā anandamides". I Pertwee RG (ed.). Nā mea loaʻa Cannabinoid. ʻO Bosetona: Hale Paʻi Kula. pp. 233–

(3). Rapino, C.; Battista, N. Bari, M. Maccarrone, M. (2014). "Endocannabinoids ma ke ʻano he biomarkers o ka hanauna kanaka". Hōʻano Hou o ke Kanaka. 20 (4): 501-516.

(4).(2015). Cannabidiol (CBD) a me kāna mau analogs: kahi loiloi i ko lākou hopena ma ka lī. ʻO Bioorganic & Medicinal Chemistry, 23 (7), 1377-1385.

(5). Corroon, J., & Phillips, JA (2018). Ke aʻo mahele ʻāpana o nā mea hoʻohana Cannabidiol. ʻO ka noiʻi cannabis a me ka cannabinoid, 3 (1), 152-161.

(6).National Center for Biotechnology Information (2020). Hōʻuluʻulu Manaʻo PubChem no CID 644019, Cannabidiol. Ua kiʻi ʻia ʻo ʻOkakopa 27, 2020, mai .

(7) .R de Mello Schier, A., P de Oliveira Ribeiro, N., S Coutinho, D., Machado, S., Arias-Carrión, O., A Crippa, J.,… & C Silva, A . (2014). ʻO ka Antidepressant-like a me nā hopena like o ka cannabidiol: kahi hui kemika o Cannabis sativa. Nā CNS & Nā Neurological Disorder-Target Target (ʻO nā pahuhopu lāʻau i kēia manawa-CNS & Nā maʻi Neurological), 13 (6), 953-960.

(8) .Binging, EM, Steenkamp, ​​MM, Manzanares, J., & Marmar, CR (2015). Cannabidiol ma ke ʻano he kūpono kūpono no nā maʻi kūpilikiʻi. Nā Neurotherapeutics: ka puke pai o ka ʻAmelika Hui Pū ʻIa no NeuroTherapeutics Hoʻokolohua12(4), 825-836.

(9).Anandamide (AEA) (94421-68-8)

(10).Huakaʻi e mākaʻikaʻi egt.

(11).Oleoylethanolamide (oea) -ʻo ka wana kupua o kou ola

(12).ʻO nā mea āpau e pono ai ʻoe e ʻike e pili ana i ka ribotide ribotide nikotinamide.

(13).ʻO nā mea kōkua Magnesium l-threonate: nā pono, nā hana, a me nā hopena ʻaoʻao.

(14).Palmitoylethanolamide (pea): nā pono, nā huahana, nā hoʻohana, nā mea hoʻohui.

(15).ʻO nā pono olakino 6 kiʻekiʻe loa o resveratrol supplement.

(16).ʻO nā pono kiʻekiʻe he 5 o ka lawe ʻana i ka phosphatidylserine (ps).

(17).ʻO 5 keu pono o ka lawe ʻana i ka quyrone pyrroloquinoline (pqq).

(18).ʻO ka waihona nootropic ʻoi loa o ka alpha gpc.

(19).ʻO ke kumukānāwai anti-ʻelemakule maikaʻi loa o nicotinamide mononucleotide (nmn).